1. Home
  2. WAI vs BOLD Comparison

WAI vs BOLD Comparison

Compare WAI & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAI
  • BOLD
  • Stock Information
  • Founded
  • WAI 2018
  • BOLD 2018
  • Country
  • WAI China
  • BOLD United States
  • Employees
  • WAI N/A
  • BOLD N/A
  • Industry
  • WAI
  • BOLD
  • Sector
  • WAI
  • BOLD
  • Exchange
  • WAI NYSE
  • BOLD Nasdaq
  • Market Cap
  • WAI 56.8M
  • BOLD 49.5M
  • IPO Year
  • WAI 2023
  • BOLD 2024
  • Fundamental
  • Price
  • WAI $0.31
  • BOLD $1.96
  • Analyst Decision
  • WAI
  • BOLD Buy
  • Analyst Count
  • WAI 0
  • BOLD 3
  • Target Price
  • WAI N/A
  • BOLD $22.50
  • AVG Volume (30 Days)
  • WAI 35.1K
  • BOLD 45.2K
  • Earning Date
  • WAI 03-04-2025
  • BOLD 04-03-2025
  • Dividend Yield
  • WAI N/A
  • BOLD N/A
  • EPS Growth
  • WAI N/A
  • BOLD N/A
  • EPS
  • WAI N/A
  • BOLD N/A
  • Revenue
  • WAI $3,989,698.00
  • BOLD N/A
  • Revenue This Year
  • WAI N/A
  • BOLD N/A
  • Revenue Next Year
  • WAI N/A
  • BOLD N/A
  • P/E Ratio
  • WAI N/A
  • BOLD N/A
  • Revenue Growth
  • WAI N/A
  • BOLD N/A
  • 52 Week Low
  • WAI $0.19
  • BOLD $1.95
  • 52 Week High
  • WAI $1.75
  • BOLD $15.24
  • Technical
  • Relative Strength Index (RSI)
  • WAI N/A
  • BOLD N/A
  • Support Level
  • WAI N/A
  • BOLD N/A
  • Resistance Level
  • WAI N/A
  • BOLD N/A
  • Average True Range (ATR)
  • WAI 0.00
  • BOLD 0.00
  • MACD
  • WAI 0.00
  • BOLD 0.00
  • Stochastic Oscillator
  • WAI 0.00
  • BOLD 0.00

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: